VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 398 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $74,218,000 | +66.3% | 2,903,660 | +45.8% | 0.18% | +60.9% |
| Q1 2019 | $44,641,000 | +84.4% | 1,991,140 | +73.4% | 0.12% | +64.3% |
| Q4 2018 | $24,213,000 | +12.9% | 1,148,100 | -0.9% | 0.07% | +29.6% |
| Q3 2018 | $21,448,000 | -68.1% | 1,158,100 | -61.6% | 0.05% | -69.8% |
| Q2 2018 | $67,221,000 | +55.4% | 3,013,030 | +53.1% | 0.18% | +53.0% |
| Q1 2018 | $43,259,000 | -5.4% | 1,968,100 | 0.0% | 0.12% | -5.6% |
| Q4 2017 | $45,739,000 | +70.5% | 1,968,100 | +68.5% | 0.12% | +57.0% |
| Q3 2017 | $26,820,000 | +6.4% | 1,168,100 | +2.4% | 0.08% | +2.6% |
| Q2 2017 | $25,195,000 | -28.7% | 1,141,100 | -26.3% | 0.08% | -31.2% |
| Q1 2017 | $35,330,000 | +400.6% | 1,548,900 | +359.1% | 0.11% | +366.7% |
| Q4 2016 | $7,058,000 | -68.1% | 337,400 | -59.7% | 0.02% | -68.0% |
| Q3 2016 | $22,126,000 | -9.9% | 837,150 | -5.6% | 0.08% | -14.8% |
| Q2 2016 | $24,563,000 | – | 886,730 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |